Valuation: Boule Diagnostics AB

Market Cap 78.44M 7.92M 7.05M 6.54M 5.92M 11.13M 751M 11.32M 30.82M 393M 29.73M 29.11M 1.25B P/E 2026 *
-8.03x
P/E 2027 * 9.13x
Enterprise Value 275M 27.78M 24.73M 22.92M 20.77M 39.03M 2.63B 39.68M 108M 1.38B 104M 102M 4.39B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.54x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day-2.88%
1 week-11.40%
Current month-12.93%
1 month-18.88%
3 months-43.89%
6 months-48.60%
Current year-58.86%
1 week 2
Extreme 2
2.26
1 month 2
Extreme 2
2.83
Current year 2
Extreme 2
5.68
1 year 2
Extreme 2
6.64
3 years 2
Extreme 2
12.62
5 years 2
Extreme 2
59.5
10 years 2
Extreme 2
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-2.88%-11.40% - - 8.16M
Average -2.88%
Weighted average by Cap. -2.88%

Financials

2026 *2027 *
Net sales 453M 45.78M 40.75M 37.76M 34.22M 64.31M 4.34B 65.39M 178M 2.27B 172M 168M 7.24B 483M 48.83M 43.46M 40.28M 36.5M 68.6M 4.63B 69.75M 190M 2.42B 183M 179M 7.72B
Net income -9.77M -987K -879K -814K -738K -1.39M -93.53M -1.41M -3.84M -48.95M -3.7M -3.63M -156M 8.6M 868K 773K 716K 649K 1.22M 82.27M 1.24M 3.38M 43.05M 3.26M 3.19M 137M
Net Debt 197M 19.86M 17.67M 16.38M 14.84M 27.9M 1.88B 28.36M 77.21M 984M 74.48M 72.93M 3.14B 185M 18.64M 16.59M 15.38M 13.93M 26.19M 1.77B 26.63M 72.49M 924M 69.92M 68.47M 2.95B
Projected Income Statement - Annual - Boule Diagnostics AB
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
20/10/26 SEK 2.020 -2.88% 28,338
19/10/26 SEK 2.080 +0.97% 12,334
16/10/26 SEK 2.060 +1.48% 62,757
15/10/26 SEK 2.030 -3.79% 56,088
14/10/26 SEK 2.110 -7.46% 86,252
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.020SEK
Average target price
3.800SEK
Spread / Average Target
+88.12%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boule Diagnostics AB
  1. Stock Market
  2. Stocks
  3. BOUL Stock